Alessa Therapeutics

Alessa Therapeutics is a private biotechnology company developing a proprietary drug-delivery platform designed for the sustained and localized release of clinically proven therapies. The company's initial focus is on creating a novel treatment for early-stage prostate cancer, aiming to improve efficacy while reducing systemic side effects. Founded in 2020, the company is based in San Diego, California.